Harvard Apparatus Regenerative Technology, Inc. (HRGN)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Harvard Apparatus Regenerative Technology, Inc. reported revenue of $704.0K, up 63.7% from the prior year. The company ran a net loss, with a net margin of -975.7%. It held $2.68M in total assets against $1.62M in total liabilities.
Key ratios (FY2025)
-982.2%
Operating margin
-975.7%
Net margin
-649.9%
Return on equity
+63.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $704.0K | $430.0K | $103.0K | — | — | — | — | — | — | — |
| Cost of Revenue | $646.0K | $270.0K | $24.0K | — | — | — | — | — | $0 | $116.0K |
| Gross Profit | — | — | — | — | — | — | — | — | $0 | -$34.0K |
| Operating Income | -$6.92M | -$7.73M | -$8.99M | -$6.15M | -$8.64M | -$5.33M | -$8.87M | -$7.84M | -$11.47M | -$12.13M |
| Net Income | -$6.87M | -$7.73M | -$8.95M | -$6.07M | -$7.98M | -$4.87M | -$8.33M | -$7.53M | -$11.92M | -$11.58M |
| EPS (Diluted) | $-0.42 | $-0.52 | $-0.67 | $-0.55 | $-0.79 | $-0.55 | — | — | — | — |
| Total Assets | $2.68M | $4.44M | $2.61M | $2.40M | $1.87M | $2.08M | $1.99M | $2.63M | $5.04M | $4.55M |
| Total Liabilities | $1.62M | $1.22M | $968.0K | $1.41M | $4.89M | $951.0K | $903.0K | $662.0K | $1.62M | $2.78M |
| Shareholders' Equity | $1.06M | $3.22M | $1.65M | -$3.19M | -$3.03M | $1.12M | $1.09M | $1.97M | $3.42M | $1.77M |
| Cash & Equivalents | $1.35M | $2.49M | $432.0K | $1.24M | — | — | — | — | $4.04M | $2.94M |
| Operating Cash Flow | -$3.83M | -$4.85M | -$6.94M | -$5.11M | -$2.63M | -$4.04M | -$6.06M | -$7.64M | -$11.01M | -$9.06M |
| Capital Expenditures | — | $0 | $11.0K | $5.0K | $0 | $7.0K | $129.0K | $131.0K | $136.0K | $302.0K |
| Shares Outstanding | 17.58M | 15.92M | 13.95M | 12.17M | 10.76M | 9.39M | 8.16M | 5.67M | 2.51M | 855.4K |